Cargando…

Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction

AIMS: The prognostic value of biomarkers in patients with heart failure (HF) and mid‐range (HFmrEF) or preserved ejection fraction (HFpEF) has not been widely addressed. The aim of this study was to assess whether the prognostic value of growth differentiation factor 15 (GDF‐15) is superior to that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendez Fernandez, Ana Belen, Ferrero‐Gregori, Andreu, Garcia‐Osuna, Alvaro, Mirabet‐Perez, Sonia, Pirla‐Buxo, Maria Jose, Cinca‐Cuscullola, Juan, Ordonez‐Llanos, Jordi, Roig Minguell, Eulàlia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524215/ https://www.ncbi.nlm.nih.gov/pubmed/32589369 http://dx.doi.org/10.1002/ehf2.12621

Ejemplares similares

High-Sensitivity Troponin T and Soluble Form of AXL as Long-Term Prognostic Biomarkers after Heart Transplantation
por: Mirabet, Sonia, et al.
Publicado: (2018)

Risk Assessment after ST-Segment Elevation Myocardial Infarction: Can Biomarkers Improve the Performance of Clinical Variables?
por: Garcia-Osuna, Alvaro, et al.
Publicado: (2022)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

A Mobile App (mHeart) to Detect Medication Nonadherence in the Heart Transplant Population: Validation Study
por: Gomis-Pastor, Mar, et al.
Publicado: (2020)

New factors in heart failure pathophysiology: Immunity cells release of extracellular vesicles
por: Vilella-Figuerola, Alba, et al.
Publicado: (2022)

Mobile Health to Improve Adherence and Patient Experience in Heart Transplantation Recipients: The mHeart Trial
por: Gomis-Pastor, Mar, et al.
Publicado: (2021)

Prevalence and prognostic impact of subclinical pulmonary congestion at discharge in patients with acute heart failure
por: Rivas‐Lasarte, Mercedes, et al.
Publicado: (2020)

Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry
por: de Frutos, Fernando, et al.
Publicado: (2020)

Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
por: Caravaca Perez, Pedro, et al.
Publicado: (2022)

A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure
por: Moliner-Abós, Carles, et al.
Publicado: (2021)

Incremental prognostic value of lung ultrasound on contemporary heart failure risk scores
por: Maestro-Benedicto, Alba, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Laparoscopic Cholecystectomy in a Cardiac Transplant Candidate with an Ejection Fraction of Less than 15%
por: Jones, Perry E., et al.
Publicado: (1998)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
por: Álvarez-García, Jesús, et al.
Publicado: (2021)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

New Cardiovascular Biomarkers in Ischemic Heart Disease—GDF-15, A Probable Predictor for Ejection Fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone
por: Lewis, Gavin A., et al.
Publicado: (2022)

Prognostic value of Growth differentiation factors 15 in Acute heart failure patients with preserved ejection fraction
por: Yin, Dan, et al.
Publicado: (2022)

Measuring affect dynamics: An empirical framework
por: Pirla, Sergio, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Heart Failure with Preserved Ejection Fraction—a Concise Review
por: Adamczak, Daria M., et al.
Publicado: (2020)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Prognostic Implications of Changes in Left Ventricular Ejection Fraction and Pulmonary Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
por: Kim, Hyun-Jin
Publicado: (2019)

Female Gender Is Associated with an Increased Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure with Reduced Ejection Fraction
por: Kewcharoen, Jakrin, et al.
Publicado: (2022)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Hyperdynamic ejection fraction in the critically ill patient
por: Paonessa, JR, et al.
Publicado: (2014)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

T1 mapping across the ejection fraction spectrum
por: Alaour, Bashir, et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dl14112gipdc1o8p2rs2s3i4jn